Trial intelligence / Profile preview

Oliceridine vs morphine for postoperative analgesia after total laparoscopic hysterectomy

ChiCTR2400086706Phase 4Recruiting

Sponsor
Anqing Municipal Hospital
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of oliceridine in postoperative pain (2 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Resting and exercise VAS pain scores. Started Aug 2024; status: recruiting.

02

Drugs

oliceridine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2400086706.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400086706.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call